| Authors: |
Damaj G; Caen University Hospital, Hematology Institute, Normandy University, School of Medicine, Caen, France., de Masson A; Department of Dermatology, Saint-Louis Hospital, AP-HP, National Reference Center for Cutaneous Lymphomas, Institut du Cancer AP-HP Nord, Université Paris Cité, Paris, France., Dreger P; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Bazarbachi A; Chair of the EBMT Lymphoma Working Party, Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon., Berning P; Department of Medicine A, University Hospital Münster, Münster, Germany., Duarte RF; Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Fox CP; School of Medicine, University of Nottingham, Nottingham, UK., Guenova E; University Institute and Clinic for Immuno-Dermatology, Medical Faculty, Johannes Kepler University, Secretary of the EORTC Cutaneous Lymphoma Tumor Group, Linz, Austria., Hermine O; Service d'Hématologie Adultes, Institut Necker Enfants Malades, Unité INSERM U1153, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Université Paris Cité and Imagine Institute, Paris, France., Kyriakou C; Secretary of the EBMT LWP, Department of Hematology, University College London Hospital, London, UK., Tanase A; Fundeni Clinical Institute, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania., Tournilhac O; Department of Hematology and Cell Therapy, Clermont-Ferrand University Hospital, UCA, EA7453 Chelter CIC-1405, Clermont-Ferrand, France., Jurczak W; Department of Clinical Oncology, Maria Sklodowska Curie National Research Institute of Oncology, Krakow, Poland., Karsten IE; Department of Medicine A, University Hospital Münster, Münster, Germany., Quoc SN; Department of Hematology and Cellular Therapies, Sorbonne University Pitié-Salpêtrière Hospital, Paris, France., Serroukh Y; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Stella F; Fondazione IRCCS Istituto Nazionale Dei Tumori Milano, University of Milano, Milan, Italy., Wulf G; Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'hospitalet, Institut de Recerca Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Papadavid E; Department of Dermatology, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Ortiz-Romero PL; Department of Dermatology Institute i+12, Hospital 12 de Octubre Medical School, University Complutense, Madrid, Spain., Ruggeri A; Co-Chair of the Practice Harmonisation and Guidelines Committee of EBMT and Chair of the CTIWP of the EBMT. Hematology and BMT Unit, IRCCS San Raffaele Hospital, Milan, Italy., Sánchez-Ortega I; Secretary of the Practice Harmonisation and Guidelines Committee of EBMT; EBMT Medical Officer, Executive Office, Barcelona, Spain., Scarisbrick JJ; University Hospital Birmingham and University of Birmingham, Birmingham, UK., Yakoub-Agha I; Chair of the EBMT Practice Harmonisation and Guidelines Committee; Lille University Hospital, Lille University, INSERM U1286, Infinite, Lille, France., Onida F; Co-Chair of the Practice Harmonisation and Guidelines Committee of the EBMT; Hematology and BMT Centre, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy., Schmitz N; Department of Medicine A, University Hospital Münster, Münster, Germany. |
